Dr. Billy Smith, MD

NPI: 1346275260
Total Payments
$14,556
2024 Payments
$1,138
Companies
46
Transactions
934
Medicare Patients
7,774
Medicare Billing
$1.3M

Payment Breakdown by Category

Food & Beverage$14,447 (99.3%)
Education$109.17 (0.7%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $14,447 926 99.3%
Education $109.17 8 0.7%

Top Paying Companies

Company Total Records Latest Year
Forte Bio-Pharma LLC $3,544 31 $0 (2024)
Collegium Pharmaceutical, Inc. $2,237 244 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $962.32 60 $0 (2024)
Daiichi Sankyo Inc. $779.05 93 $0 (2019)
SCILEX PHARMACEUTICALS INC. $752.60 46 $0 (2024)
ABBVIE INC. $574.24 49 $0 (2024)
Pernix Therapeutics Holdings, Inc. $416.34 40 $0 (2019)
RedHill Biopharma Inc. $387.63 24 $0 (2022)
Sentynl Therapeutics, Inc. $324.49 22 $0 (2018)
Teva Pharmaceuticals USA, Inc. $312.13 25 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,138 62 Valinor Pharma, LLC ($214.99)
2023 $1,682 103 Forte Bio-Pharma LLC ($352.73)
2022 $1,423 82 FORTE BIO-PHARMA LLC ($295.07)
2021 $2,020 143 Forte Bio-Pharma LLC ($386.53)
2020 $1,306 92 Collegium Pharmaceutical, Inc. ($387.35)
2019 $1,688 145 Collegium Pharmaceutical, Inc. ($407.22)
2018 $3,660 147 Forte Bio-Pharma LLC ($2,029)
2017 $1,639 160 Sentynl Therapeutics, Inc. ($229.33)

All Payment Transactions

934 individual payment records from CMS Open Payments — Page 1 of 38

Date Company Product Nature Form Amount Type
12/12/2024 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $20.59 General
Category: Opioid Analgesic
11/20/2024 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $21.23 General
Category: Opioid Analgesic
11/19/2024 Braeburn Inc. BRIXADI (Drug) Food and Beverage In-kind items and services $22.95 General
Category: Opioid Use Disorder
10/25/2024 VERTEX PHARMACEUTICALS INCORPORATED Food and Beverage In-kind items and services $23.35 General
10/23/2024 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $18.26 General
Category: NEUROSCIENCE
10/23/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $15.99 General
Category: NEUROSCIENCE
10/17/2024 IDORSIA PHARMACEUTICALS US INC QUVIVIQ (Drug) Food and Beverage In-kind items and services $15.67 General
Category: Insomnia
10/16/2024 Valinor Pharma, LLC MOVANTIK (Drug) Food and Beverage In-kind items and services $16.64 General
Category: GASTROENTEROLOGY
10/15/2024 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $24.99 General
Category: Opioid Analgesic
10/02/2024 Indivior Inc. SUBLOCADE (Drug) Food and Beverage In-kind items and services $21.63 General
Category: OUD
09/24/2024 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $19.37 General
Category: Opioid Analgesic
09/17/2024 Braeburn Inc. BRIXADI (Drug) Food and Beverage In-kind items and services $21.51 General
Category: Opioid Use Disorder
09/17/2024 Valinor Pharma, LLC MOVANTIK (Drug) Food and Beverage In-kind items and services $3.00 General
Category: GASTROENTEROLOGY
09/05/2024 SCILEX PHARMACEUTICALS INC. ZTLido (Drug) Food and Beverage In-kind items and services $20.16 General
Category: Analgesic
09/04/2024 Valinor Pharma, LLC MOVANTIK (Drug) Food and Beverage In-kind items and services $16.21 General
Category: GASTROENTEROLOGY
08/27/2024 Forte Bio-Pharma LLC NALOCET (Drug), PROLATE, PROLATE Food and Beverage In-kind items and services $18.26 General
Category: PAIN
08/14/2024 Valinor Pharma, LLC MOVANTIK (Drug) Food and Beverage In-kind items and services $12.10 General
Category: GASTROENTEROLOGY
08/09/2024 Forte Bio-Pharma LLC NALOCET (Drug), PROLATE, PROLATE Food and Beverage In-kind items and services $17.08 General
Category: PAIN
08/07/2024 Braeburn Inc. BRIXADI (Drug) Food and Beverage In-kind items and services $24.20 General
Category: Opioid Use Disorder
08/01/2024 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $23.69 General
Category: Opioid Analgesic
07/23/2024 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $3.46 General
Category: Opioid Analgesic
07/18/2024 SCILEX PHARMACEUTICALS INC. ZTLido (Drug) Food and Beverage In-kind items and services $19.65 General
Category: Analgesic
07/11/2024 Valinor Pharma, LLC MOVANTIK (Drug) Food and Beverage In-kind items and services $17.85 General
Category: GASTROENTEROLOGY
07/10/2024 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $24.01 General
Category: Opioid Analgesic
06/27/2024 SCILEX PHARMACEUTICALS INC. ZTLido (Drug) Food and Beverage In-kind items and services $24.56 General
Category: Analgesic

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 1,337 3,994 $378,255 $229,674
2022 7 1,646 5,101 $485,959 $299,739
2021 10 2,176 6,908 $665,089 $425,397
2020 12 2,615 7,445 $687,178 $374,823
Total Patients
7,774
Total Services
23,448
Medicare Billing
$1.3M
Procedure Codes
36

All Medicare Procedures & Services

36 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 456 1,805 $162,450 $105,558 65.0%
80307 Testing for presence of drug, by chemistry analyzers Office 2023 454 1,405 $126,450 $84,776 67.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 347 593 $77,090 $33,707 43.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 41 41 $8,200 $4,533 55.3%
20610 Aspiration and/or injection of fluid from large joint Office 2023 13 25 $3,495 $884.58 25.3%
J1040 Injection, methylprednisolone acetate, 80 mg Office 2023 11 17 $278.12 $142.96 51.4%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2023 15 108 $291.60 $71.46 24.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 559 2,250 $202,500 $119,811 59.2%
80307 Testing for presence of drug, by chemistry analyzers Office 2022 568 1,686 $151,740 $102,528 67.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 408 890 $115,700 $70,279 60.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 52 52 $10,400 $5,490 52.8%
20610 Aspiration and/or injection of fluid from large joint Office 2022 22 35 $4,893 $1,374 28.1%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2022 26 172 $464.40 $129.57 27.9%
J1040 Injection, methylprednisolone acetate, 80 mg Office 2022 11 16 $261.76 $127.34 48.6%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 720 3,089 $278,010 $174,986 62.9%
80307 Testing for presence of drug, by chemistry analyzers Office 2021 721 2,315 $208,350 $142,591 68.4%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 496 1,057 $137,410 $89,721 65.3%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 94 94 $18,800 $9,900 52.7%
20610 Aspiration and/or injection of large joint or joint capsule Office 2021 35 57 $7,829 $2,546 32.5%
62323 Injection of substance into spinal canal of lower back or sacrum using imaging guidance Office 2021 13 14 $5,852 $2,422 41.4%
27096 Injection procedure into sacroiliac joint for anesthetic or steroid Office 2021 14 17 $5,743 $1,990 34.6%
95885 Needle measurement and recording of electrical activity of muscles of arm or leg limited study Office 2021 12 14 $1,789 $680.70 38.1%
J1040 Injection, methylprednisolone acetate, 80 mg Office 2021 33 46 $752.56 $374.80 49.8%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2021 38 205 $553.50 $187.27 33.8%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 873 4,008 $360,720 $180,397 50.0%

About Dr. Billy Smith, MD

Dr. Billy Smith, MD is a Physical Medicine & Rehabilitation healthcare provider based in Greenville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346275260.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Billy Smith, MD has received a total of $14,556 in payments from pharmaceutical and medical device companies, with $1,138 received in 2024. These payments were reported across 934 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($14,447).

As a Medicare-enrolled provider, Smith has provided services to 7,774 Medicare beneficiaries, totaling 23,448 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.

Practice Information

  • Specialty Physical Medicine & Rehabilitation
  • Location Greenville, NC
  • Active Since 07/11/2006
  • Last Updated 11/28/2018
  • Taxonomy Code 208100000X
  • Entity Type Individual
  • NPI Number 1346275260

Products in Payments

  • Nalocet (Drug) $2,310
  • XTAMPZA (Drug) $1,967
  • NALOCET (Drug) $917.93
  • RELISTOR (Drug) $839.23
  • Morphabond ER (Drug) $656.20
  • ZTLido (Drug) $589.15
  • Movantik (Drug) $510.48
  • MOVANTIK (Drug) $493.88
  • UBRELVY (Drug) $441.22
  • ZOHYDRO ER (Drug) $346.13
  • Levorphanol (Drug) $324.49
  • PROLATE (Drug) $315.48
  • NURTEC ODT (Drug) $289.99
  • SUBLOCADE (Drug) $282.69
  • Horizant (Drug) $282.62
  • Evzio (Drug) $249.51
  • SUBSYS (Drug) $247.27
  • RELISTOR ORAL (Drug) $246.20
  • QULIPTA (Drug) $203.43
  • LEVORPHANOL TARTRATE (Drug) $162.01

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physical Medicine & Rehabilitation Doctors in Greenville